| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/30/2007 | US20070202116 Staphylococcal infections using glycopeptide antibiotic eg vancomycin |
| 08/30/2007 | US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 08/30/2007 | US20070202114 Higher gene expression in sample indicates tumor is tamoxifen-resistant; drug screening |
| 08/30/2007 | US20070202113 Cell surface glycoprotein specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 08/30/2007 | US20070202112 Detecting vimentin expression and secretion and for characterizing cancer ( prostate cancer); |
| 08/30/2007 | US20070202111 Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis |
| 08/30/2007 | US20070202110 Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer |
| 08/30/2007 | US20070202109 Method Of Diagnosing Breast Cancer |
| 08/30/2007 | US20070202108 Antithrombotic agents; monoclonal antibody that inhibits collagen-induced platelet aggregation at an IC50 of less than 7 mu g/ml |
| 08/30/2007 | US20070202107 Novel kinases |
| 08/30/2007 | US20070202106 Compositions and methods for the treatment of cancer |
| 08/30/2007 | US20070202105 Recombinant immunoglobulin specific to tumor necrosis factor for treatment and prevention of sepsis, infection and autoimmune diseases |
| 08/30/2007 | US20070202104 Treatment of spondyloarthropathies using TNFalpha inhibitors |
| 08/30/2007 | US20070202103 Compounds For Targeting |
| 08/30/2007 | US20070202102 High-Yield Method For The Production Of Human Antibodies Blocking The Biological Activity Of A Human Cytokine |
| 08/30/2007 | US20070202101 Combination therapy using anti-EGFR antibodies and anti-hormonal agents |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | US20070202099 Antibody Drug |
| 08/30/2007 | US20070202098 Her2/neu OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION |
| 08/30/2007 | US20070202097 Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof |
| 08/30/2007 | US20070202096 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 08/30/2007 | US20070202045 Serum albumin binding peptides for tumor targeting |
| 08/30/2007 | US20070202044 Antibody therapy |
| 08/30/2007 | US20070202043 Cell surface glycoprotein specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 08/30/2007 | US20070202042 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 141205-02; customization of therapy for each individual; kits |
| 08/30/2007 | US20070202041 Cancerous disease modifying antibodies |
| 08/30/2007 | DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins |
| 08/30/2007 | DE19627193B4 Rekombinantes myxomatisches Virus Recombinant virus myxomatisches |
| 08/30/2007 | CA2661700A1 Nanoparticles for immunotherapy |
| 08/30/2007 | CA2645414A1 Method for screening hiv drug sensitivity |
| 08/30/2007 | CA2643819A1 Pseudoinfectious flavivirus and uses thereof |
| 08/30/2007 | CA2643791A1 Attenuated francisella and methods of use |
| 08/30/2007 | CA2643603A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 08/30/2007 | CA2643565A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 08/30/2007 | CA2643561A1 Cancerous disease modifying antibody 141205-05 |
| 08/30/2007 | CA2643555A1 Cytotoxicity mediation of cells evidencing surface expression of cd59 |
| 08/30/2007 | CA2643200A1 Production of biologically active proteins |
| 08/30/2007 | CA2643144A1 Cancerous disease modifying antibody 141205-04 |
| 08/30/2007 | CA2643063A1 Cancerous disease modifying antibody 141205-02 |
| 08/30/2007 | CA2643059A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 08/30/2007 | CA2638851A1 Thymic stromal lymphopoietin (tslp) antibodies and uses thereof |
| 08/30/2007 | CA2638841A1 Anti-amyloid immunogenic compositions, methods and uses |
| 08/30/2007 | CA2638775A1 Peptide vaccine for inducing production of anti-amyloid-.beta.-peptide antibody |
| 08/30/2007 | CA2630218A1 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/30/2007 | CA2628253A1 Therapeutic anti-her2 antibody fusion polypeptides |
| 08/30/2007 | CA2626100A1 Treatment for antiphospholipid-syndrome-related pregnancy complications |
| 08/29/2007 | EP1826264A1 Primate model for orthopox virus infections |
| 08/29/2007 | EP1826218A1 Antihuman baff antibody |
| 08/29/2007 | EP1826217A1 Method for identification of antigenic peptides |
| 08/29/2007 | EP1825864A2 Antithrombotic agents |
| 08/29/2007 | EP1825863A1 Recombinant porcine adenovirus vector |
| 08/29/2007 | EP1825005A2 Mer diagnostic and therapeutic agents |
| 08/29/2007 | EP1825003A2 Identification and use of prognostic and predictive markers in cancer treatment |
| 08/29/2007 | EP1824990A2 Methods of producing influenza vaccine compositions |
| 08/29/2007 | EP1824978A1 Hcv f protein and uses thereof |
| 08/29/2007 | EP1824973A1 Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound |
| 08/29/2007 | EP1824887A2 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 08/29/2007 | EP1824886A2 Fully human monoclonal antibodies to il-13 |
| 08/29/2007 | EP1824885A1 Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 08/29/2007 | EP1824514A2 Toll like receptor 3 antagonists, methods and uses |
| 08/29/2007 | EP1824513A2 Treatment of b-cell malignancies |
| 08/29/2007 | EP1824512A2 Improved dna immunization with recombinase/transposase |
| 08/29/2007 | EP1824511A2 Adjuvant activity of gastrointestinal peptides |
| 08/29/2007 | EP1824510A2 Use of flagellin in the immunotherapy of yersinia pestis |
| 08/29/2007 | EP1824509A2 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 08/29/2007 | EP1824508A1 T-cell modulation |
| 08/29/2007 | EP1824454A2 Targeted iron chelator delivery system |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1140997B1 Chlamydia trachomatis antigens |
| 08/29/2007 | EP1140024B1 Particles for oral delivery of peptides and proteins |
| 08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/29/2007 | EP1032269B1 Treatment of neoplasms with interferon-sensitive, clonal viruses |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | EP0998585B1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 08/29/2007 | EP0983086B1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME |
| 08/29/2007 | EP0763059B1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 08/29/2007 | CN101027391A Methods and compositions for improving recombinant protein production |
| 08/29/2007 | CN101027322A 促红细胞生成素受体结合抗体 Erythropoietin receptor antibody |
| 08/29/2007 | CN101027319A 肝素结合肽 Heparin-binding peptides |
| 08/29/2007 | CN101027317A HPV vaccine comprising peptides from host cell proteins |
| 08/29/2007 | CN101027100A Method for treating sjogren's syndrome |
| 08/29/2007 | CN101027085A Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 08/29/2007 | CN101027084A Mutated HIV NEF for modulating immunity |
| 08/29/2007 | CN101027083A Clostridial neurotoxins for use in tissue healing |
| 08/29/2007 | CN101027081A Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 08/29/2007 | CN101027073A Natriuretic compounds, conjugates, and uses thereof |
| 08/29/2007 | CN101027046A Stabilization of alum-adjuvanted immunologically active agents |
| 08/29/2007 | CN101024845A 方法 Method |
| 08/29/2007 | CN101024842A Expression vectors encoding epitopes of target-associated antigens and its design method |
| 08/29/2007 | CN101024089A Function of E4BP4 gene inplantation course and use thereof |
| 08/29/2007 | CN101024081A H9 sub-type fowl-flu III stibilized antigen |
| 08/29/2007 | CN101024080A Dolphin streptococcal white-oil adjuvant inactivated vaccine and preparing method |
| 08/29/2007 | CN101024079A Pneumo-streptococcal-polysaccharide adventitia jointed vaccine and preparing method |
| 08/29/2007 | CN101024078A Use of short-small-rod like bacillus for preparing pig's infections pleuropneumonia biological preparation |
| 08/29/2007 | CN101024077A Tubercle-bacillus recombined vaccine |
| 08/29/2007 | CN101024076A Novel use of coccidium |
| 08/29/2007 | CN100334228C Cimeric immunomodulatory compounds and methods of using the same |
| 08/29/2007 | CN100334217C Recombinant chicken Marek's disease virus transfer vector and application thereof |
| 08/29/2007 | CN100334112C Interfusion protein of human interleukin 15 and Fe |
| 08/29/2007 | CN100333794C Adjuvanted genetic vaccines |